Featured Issue Briefs
The Battle on the Home Front: Jonathan Gadsden's Story
Marine Lance Corporal's story reflects the growing need for new antibiotics that can treat dangerous diseases, against which most drugs are useless. Read More
Facilitating Medical Device Innovation: De Novo Reform
The de novo process -- which requests lower-risk reclassification of medical devices and entry into the marketplace -- as it exists now is not achieving its purpose and has instead added unnecessary and time-consuming requirements. Read More
Food Products Recalled by FDA
Since President Obama signed the FDA Food Safety Modernization Act into law, at least 149 FDA-regulated food products have been recalled due to potential pathogenic contamination. Read More
More Issue Briefs
| Date | Issue Briefs | Topic |
|---|---|---|
| Jan 28, 2004 |
Statement of The Honorable Bill Frenzel, Chairman, Pew Commission on Children in Foster CareFor the last nine months, I have been privileged to chair the Pew Commission on Children in Foster Care, a task I share with my colleague, former Representative Bill Gray. This independent, nonpartisan commission, funded by The Pew Charitable Trusts, includes some of the wisest and most experienced individuals in the field of child welfare. You heard from one of them this morning, New York City Commissioner William Bell. The other members of our Commission are no less impressive. More info |
Health Topics |
| Nov 21, 2012 |
Strengthening Our National System for Medical Device Postmarket SurveillanceThe Medical Device Initiative submitted comments to the U.S. Food and Drug Administration concerning the FDA's National Medical Device Postmarket Surveillance Plan, "Strengthening Our National System for Medical Device Postmarket Surveillance." More info |
Drugs and Devices at the FDA |
| Oct 3, 2006 |
Subprime LendingHomeownership is the cornerstone of the American middle class and the foundation of the American dream. Low-interest rates, Wall Street demand for mortgage debt securities and new mortgage products have enabled millions of Americans to buy homes for the first time in their lives. More info |
Consumer Financial Security |
| Jul 14, 2010 |
Supporting Materials: Hearing on Antibiotic Resistance and the use of Antibiotics in Animal AgricultureOn July 14, 2010, the House Energy and Commerce Subcommittee on Health held a hearing to examine the use of antibiotics in animal agriculture. View PDF files of some of the materials entered into the hearing record by organizations and health and agricultural professionals. More info |
Antibiotics in Food Animal Production |
| Mar 17, 2009 |
Teleconference on Legislation to Help Curtail Overuse of Antibiotics on Factory FarmsChipotle restaurant CEO joins Rep. Louise Slaughter (D-NY) and leading antibiotic expert to discuss the Preservation of Antibiotics for Medical Treatment Act of 2009. More info |
Antibiotics in Food Animal Production |
| Apr 18, 2012 |
Testimony before the Committee on Energy and Commerce Subcommittee on HealthU.S. House of Representatives PDF Download Since 1992, user fee agreements have given FDA significant and sustained resources that allow the agency to review new products quickly. In fact, preliminary findings of a study that Pew has funded show that FDA reviews new drugs faster than its cou More info |
Drug Safety |
| Apr 13, 2011 |
Testimony before the Committee on Energy on Commerce, Subcommittee on Oversight and Investigations, United States House of Representatives"Chairman Stearns, Ranking Member DeGette, and members of the Oversight and Investigations Subcommittee, thank you for the opportunity to submit testimony about the essential steps Congress must take to protect Americans and ensure the integrity of our drug supply..." More info |
Drug Safety |
| Mar 8, 2012 |
Testimony before the House Committee on Energy and Commerce, Subcommittee on HealthAllan Coukell, Director of Medical Programs, and Sharon Ladin, Director of the Antibiotics and Innovation Project, testify before the House Committee on Energy and Commerce, Subcommittee on Health on stimulating the development of new antibiotics urgently needed to fight serious and life-threatening bacterial infections. More info |
Drug Safety, Antibiotic Innovation |
| Mar 29, 2012 |
Testimony before the Senate Committee on Health, Education, Labor and PensionsAllan Coukell, Director of Medical Programs, Pew Health Group: Chairman Harkin, Ranking Member Enzi, and members of this committee, thank you for the opportunity to testify about the importance of the user fee agreement legislation to patients. More info |
Drug Safety, Drugs and Devices at the FDA |
| Jul 25, 2012 |
Testimony of Allan Coukell Before the Committee on Commerce, Science and TransportationPew's Allan Coukell submitted a statement of record to the Congressional Committee on Commerce, Science and Transportation regarding concerns with the pharmaceutical supply chain. The focus of Coukell's testimony was the drug distribution system – the weaknesses in the system and the risks of counterfeit and stolen drugs. More info |
Drug Safety |
